CN Patent

CN118948848A — 用于治疗免疫缺陷病的方法

Assigned to X4 Pharmaceuticals Inc · Expires 2024-11-15 · 2y expired

What this patent protects

本申请涉及用于治疗免疫缺陷病的方法。本发明涉及治疗患有WHIM综合征或相关病症，例如中性粒细胞骨髓保留症的患者的方法，其中给予X4P‑001以降低CXCR4的活性。所述方法显示出人意料的效力，具有相对较低的毒性。

USPTO Abstract

本申请涉及用于治疗免疫缺陷病的方法。本发明涉及治疗患有WHIM综合征或相关病症，例如中性粒细胞骨髓保留症的患者的方法，其中给予X4P‑001以降低CXCR4的活性。所述方法显示出人意料的效力，具有相对较低的毒性。

Drugs covered by this patent

Patent Metadata

Patent number
CN118948848A
Jurisdiction
CN
Classification
—
Expires
2024-11-15
Drug substance claim
No
Drug product claim
No
Assignee
X4 Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.